INDEPENDENT INTELLIGENCE
LATESTSEARCH ⌕
NASDAQ / LIVE COMPANY INTELLIGENCE

Insight Molecular Diagnostics Inc.

Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.

TICKERIMDX
CORENasdaq-listed company
WATCHEarnings + filings + operating news
STATUSContinuously updated
LIVE / IMDX COVERAGE

What’s moving Insight Molecular Diagnostics Inc. now

Current reporting with the operating signal separated from the noise.

01
Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc.

The story matters when it changes Insight Molecular Diagnostics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
02
Insight Molecular Diagnostics Inc. (IMDX) Shareholder/Analyst Call Prepared Remarks Transcript

Insight Molecular Diagnostics Inc. (IMDX) Shareholder/Analyst Call Prepared Remarks Transcript

Investors are testing whether Insight Molecular Diagnostics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
03
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q1 2026 Earnings Call Transcript

Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q1 2026 Earnings Call Transcript

Investors are testing whether Insight Molecular Diagnostics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
04
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q4 2025 Earnings Call Transcript

Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) Q4 2025 Earnings Call Transcript

Investors are testing whether Insight Molecular Diagnostics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
05
Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Earnings Call Transcript

Insight Molecular Diagnostics Inc. (IMDX) Q4 2025 Earnings Call Transcript

Investors are testing whether Insight Molecular Diagnostics Inc.’s operating performance supports its strategy and valuation.

Watch next: the filing, cash flow, guidance and capital-expenditure plan.
06
Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

Oncocyte Changes Name to Insight Molecular Diagnostics Inc. (iMDx), Moves Headquarters to Nashville

The story matters when it changes Insight Molecular Diagnostics Inc.’s customers, execution, competitive position or capital requirements.

Watch next: confirmation in a company filing, official release or regulator record.
PRIMARY DOCUMENTS / SEC EDGAR

Latest IMDX filings.

Investor-relevant reports are shown first, followed by the company’s other recent official submissions.

10-QQuarterly financial reportFiled 2026-05-13 · Period 2026-03-31SEC ↗10-QQuarterly financial reportFiled 2025-11-10 · Period 2025-09-30SEC ↗10-KAnnual financial reportFiled 2026-03-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-06-17 · Period 2026-06-11SEC ↗8-KMaterial company eventFiled 2026-05-13 · Period 2026-05-13SEC ↗8-K/AMaterial company eventFiled 2026-05-13 · Period 2026-02-20SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-30 · Period 2026-04-30SEC ↗S-8Official SEC filingFiled 2026-07-24SEC ↗
EARNINGS / QUARTERLY TRACKER

Insight Molecular Diagnostics Inc., quarter by quarter.

Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.